BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7031290)

  • 1. [Present status and future problems in non-Hodgkin's lymphoma. III. On the chemotherapy of non-Hodgkin's lymphoma (author's transl)].
    Sakano T
    Rinsho Ketsueki; 1981 Feb; 22(2):159-77. PubMed ID: 7031290
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of treatment of advanced cases of non-Hodgkin's-lymphoma (author's transl)].
    Kotlarek-Haus S; Nowicka J; Gabryś K; Starzyk H; Becker M; Kaiser A; Hinrle Z
    Przegl Lek; 1979; 36(7):567-71. PubMed ID: 504706
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of two combination chemotherapies in previously untreated non Hodgkin's lymphoma.
    Somoza N; Pavlovsky S; Suárez A; Morgenfeld M; Besuschio SC; Bezares R; Quiroga Micheo E; Lein JM; De María H
    Medicina (B Aires); 1981; 41 Suppl():35-43. PubMed ID: 7345350
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of two drug combination in non-Hodgkin's lymphoma (author's transl)].
    Somoza N; Morgenfeld MC; Magnasco J; Pavlovsky S; Cavagnaro FJ; Saslavsky J; de Maria H; Macchi A; Suárez A
    Sangre (Barc); 1978; 23(4):418-25. PubMed ID: 705564
    [No Abstract]   [Full Text] [Related]  

  • 5. [Maintenance treatment in non-Hodgkin's malignant lymphoma].
    Geib KR; Guran M; Sighetea E
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(5):397-402. PubMed ID: 6143357
    [No Abstract]   [Full Text] [Related]  

  • 6. [VCP therapy for non-Hodgkin's lymphoma advanced more than stage IIB].
    Kuraishi Y; Ozeki H; Takasaki N; Mashizu N; Nagamine D; Usui N; Yamazaki H; Nakamura T; Aiba K; Yokoyama K
    Rinsho Ketsueki; 1984 Nov; 25(11):1731-7. PubMed ID: 6543455
    [No Abstract]   [Full Text] [Related]  

  • 7. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of non-Hodgkin's lymphoma. Standard treatment.
    Bunting WL
    Ariz Med; 1974 Jun; 31(6):429-31. PubMed ID: 4135460
    [No Abstract]   [Full Text] [Related]  

  • 9. [Non-Hodgkin's lymphoma and pregnancy treated with chemotherapy. Report of a case].
    Amaro A; Beristain C; Cárdenas JL; Mancera VJ; Ramírez G
    Ginecol Obstet Mex; 1981 Feb; 49(292):117-21. PubMed ID: 6895203
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term responders of non-Hodgkin's lymphoma: patients treated with combination chemotherapy].
    Nishihara R; Ohnoshi T; Oka A; Hayashi K; Sato M; Ueoka H; Yasuoka M; Sando Y; Kimura I
    Rinsho Ketsueki; 1982 Aug; 23(8):1192-7. PubMed ID: 6183469
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients].
    Izumi T; Muroi K; Hoshino Y; Komatsu N; Ohtsuki T; Yamada M; Tomizuka H; Hatake K; Furusawa S; Miura Y
    Gan To Kagaku Ryoho; 1996 May; 23(6):797-800. PubMed ID: 8645033
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current status of chemotherapy of non-Hodgkin's lymphoma in Japan and Western countries (author's transl)].
    Sakano T
    Rinsho Hoshasen; 1979; 24(10):1227-39. PubMed ID: 502075
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy of non-hodgkin's lymphomas (author's transl)].
    Fereberger W; Neubauer M
    Acta Med Austriaca; 1981; 8(1):1-6. PubMed ID: 7234308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-Hodgkin's lymphoma in children: present treatment strategy (author's transl)].
    Maurus R; Otten J
    Rev Med Brux; 1981 Mar; 2(3):259-63. PubMed ID: 7232937
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of histologic subtype on toxicity and response to chemotherapy in non-hodgkin's lymphoma. An Eastern Cooperative Oncology Group Study utilizing the BCVP regimen.
    Oken MM; Costello WG; Johnson GJ; Lenhard RE; Ezdinli EZ; Orlow E; Barnes JM; Berard CW; Glick JH
    Cancer; 1983 May; 51(9):1581-6. PubMed ID: 6339028
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy of non-Hodgkin lymphoma by the COP schedule].
    Krajewska B; Solska E; Dziewulska-Bokiniec A
    Wiad Lek; 1981 May; 34(10):815-9. PubMed ID: 7293181
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recent progress in the chemotherapy of malignant lymphoma].
    Tobinai K
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):437-43. PubMed ID: 7887635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy of childhood non-Hodgkin's lymphomas.
    Mott MG
    Cancer Treat Rep; 1981; 65 Suppl 1():119-23. PubMed ID: 6895715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
    Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K
    Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532
    [No Abstract]   [Full Text] [Related]  

  • 20. Deferral of initial therapy for advanced indolent lymphomas.
    Portlock CS
    Cancer Treat Rep; 1982 Mar; 66(3):417-9. PubMed ID: 7037178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.